The second-generation antihistamines
- 17 May 1991
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 89 (6) , 87-99
- https://doi.org/10.1080/00325481.1991.11700919
Abstract
Physicians often are faced with the decision of whether to prescribe a drug for its positive therapeutic effects or avoid prescribing it because of unacceptable side effects. This dilemma can sometimes be eased by keeping current on new therapeutic options as they become available. The authors provide a useful update on the state of the art in antihistamine therapy.Keywords
This publication has 13 references indexed in Scilit:
- Pharmacology of antihistaminesJournal of Allergy and Clinical Immunology, 1990
- Performance effects of antihistaminesJournal of Allergy and Clinical Immunology, 1990
- Antihistamine- and Decongestant-Induced Performance DecrementsJournal of Occupational and Environmental Medicine, 1990
- Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reactionJournal of Allergy and Clinical Immunology, 1989
- Antihistamines in asthmaJournal of Allergy and Clinical Immunology, 1989
- LoratadineDrugs, 1989
- Chronic urticaria: Review of nonsedating H1 antihistamines in treatmentJournal of the American Academy of Dermatology, 1988
- H receptor antagonist treatment of chronic rhinitisJournal of Allergy and Clinical Immunology, 1988
- Treatment of bronchial asthma with terfenadine; a randomized controlled trial.British Journal of Clinical Pharmacology, 1987
- Astemizole, a potent histamine H1‐receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.British Journal of Clinical Pharmacology, 1984